By disruption of the repressive control exerted by SS18-SSX-containing chromatin remodeling complexes, HDACi have been proposed to reactivate an EGR1-PTEN pathway promoting AKT inhibition and SS cell death [19, 21, 22]. The gene discussed is AKT1; the disease is synovial sarcoma.